Melbourne · Pre-Seed–Series A · 1 people tracked
Find your way into Brandon BioCatalyst
322 people in our graph share verified history with the Brandon BioCatalyst team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Brandon BioCatalyst focuses on translating medical science from research into commercial ventures across the life sciences. Rather than acting purely as a capital provider, it uses a hands-on venture model, partnering with entrepreneurs to build and operate companies. Its interests span cancer, molecular bioscience, metabolic and musculoskeletal medicine, infection and immunity, and broader biotech and medtech innovations. Backed by a collaboration of superannuation funds, CSL, national and state governments, and medical research institutes, the fund aims to accelerate medical innovation and bring novel therapeutics and diagnostics to patients.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from the firm's website
What they invest in
from 7 of 11 portfolio companiesBiotech ×6Healthtech ×6Medical Devices ×6Deep Tech ×2Digital Health ×2FemTech ×1Longevity ×1
HQs:Australia×4United States×3
Investments · 11 tracked
founders shown can be your intro pathGeorge Medicines develops single-pill combination therapies for cardiometabolic diseases such as hypertension and diabetes, leveraging research from The George Institute for Global Health.
BiotechDigital HealthHealthtechMedical Devices
Mark Mallon(Chief Executive Officer)inProfessor Anthony Rodgers(Chief Medical Officer)Dr Karl Roberts(Chief Operating Officer)in
Co-investorsBrandon Capital Partners
Q-Sera is a biotech company backed by Australian investors Uniseed and Brandon BioCatalyst, emerging from University of Queensland commercialisation efforts.
BiotechHealthtechMedical DevicesBrisbane, AU
Michael Grant(Chief Executive Officer)in
Co-investorsStoic VCUniSeed Pty Ltd.
Commenced a Phase I safety study in patients with early Alzheimer's disease.
ENA Respiratory develops and brings respiratory treatments to market across the US and other regions.
BiotechHealthtechMedical DevicesMelbourne, AU
Christophe Demaison(CEO)in
Co-investorsStoic VCUniSeed Pty Ltd.
Glyscend Therapeutics is a clinical-stage biopharmaceutical company developing oral, first-in-class therapies for type 2 diabetes and obesity.
BiotechDeep TechDigital HealthHealthtechLongevityBaltimore, US
Ashish Nimgaonkar(Executive Officer, Director)Dennis McWilliams(Director)inCasey Cunningham(Director)Leighton Read(Director)inBob Soh(Director)in
Co-investorsBrandon Capital Partners
Therapies for fibrotic and inflammatory diseases associated with diabetes complications
Co-investorsStoic VCBrandon Capital Partners
OncoRes Medical develops an intraoperative imaging technology that combines optical coherence tomography (OCT) and elastography to give surgeons real-time assessment of tissue microstructure at a resolution comparable to histology.
Deep TechHealthtechMedical DevicesPerth, AU
Co-investorsRadar Ventures
Brandon Capital is a venture capital firm that transforms medical research breakthroughs into therapeutic products, supporting life science companies from early-stage through commercialization.
BiotechMedical DevicesSan Francisco, US
Co-investorsBrandon Capital Partners
Clinical-stage biotech developing Q-122, an orally bioavailable small molecule for treating endocrine therapy-induced hot flashes in breast cancer patients.
Co-investorsStoic VC
QUE Oncology develops Q-122, a non-hormonal therapeutic candidate in clinical development for treating vasomotor symptoms in postmenopausal women and cancer patients on hormone therapy.
BiotechFemTechHealthtechMedical DevicesAtlanta, US
Co-investorsStoic VC
Portfolio news
latest coverage across their companiesFrequently asked questions
- How many investments has Brandon BioCatalyst made?
- Brandon BioCatalyst has 9 tracked investments.
- What stage does Brandon BioCatalyst invest at?
- Brandon BioCatalyst invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Brandon BioCatalyst focus on?
- Brandon BioCatalyst focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Brandon BioCatalyst located?
- Brandon BioCatalyst is headquartered in Melbourne, AU.
- Does Brandon BioCatalyst lead rounds?
- Yes, Brandon BioCatalyst leads investment rounds.
- Who does Brandon BioCatalyst co-invest with?
- Brandon BioCatalyst most often shares deals with Stoic VC, Brandon Capital Partners, Radar Ventures, among 3 tracked co-investors.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Arboretum Ventures is a Midwest-based healthcare venture capital firm that invests in early-stage healthcare startups across medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharma adjacencies.
Epidarex Capital is a transatlantic venture capital firm focused on early-stage life science companies, backing founders building businesses in emerging innovation hubs.
Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.